Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue SUPPL. 1, 2007, Pages

  Kojima, Hideyuki ^a   Sakurai, Shinya ^a   Uemura, Masahito ^a   Fukui, Hiroshi ^a   Morimoto, Hiroyo ^b   Tamagawa, Yasuhiro ^b  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b Kokuho Central Hospital   (Japan)

Author keywords

Mitochondrial Abnormality; Nonalcoholic Steatohepatitis; Oxidative Stress; Reactive Oxygen Species

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME BLOOD LEVEL; FAT CONTENT; FEMALE; HEPATITIS; HUMAN; LIVER; MALE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN; STAINING; VOLUNTEER;

ADULT; ASPARTATE AMINOTRANSFERASES; BIOPSY; DINOPROST; FATTY LIVER; FEMALE; GLUTATHIONE; HUMANS; LIVER; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; REFERENCE VALUES; SPLEEN; STATISTICS AS TOPIC; TOMOGRAPHY, X-RAY COMPUTED; TYROSINE;

EID: 33846330186     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2006.00288.x     Document Type: Conference Paper

References (16)

1. Adler M, Schaffner F (1979) Fatty liver hepatitis and cirrhosis in obese patients. Am JMed 67:811-816.
2. Caldwell SH, Swerdlow RH, Khan EM, Iezzoni JC, Hespenheide EE, Parks JK, Parker WD Jr. (1999) Mitochondrial abnormalities in non-alcoholic steatohepatitis. J Hepatol 31:430-434.
3. Chitturi S, Farrell GC (2001) Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21:27-41.
4. Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114:842-845.
5. Dominique P, Alain B, Bernard F, Abdellah M (2001) Mitochondria in steatohepatitis. Semin Liver Dis 21:57-69.
6. Foschini MP, Macchia S, Losi, Dei Tos AP, Pasquinelli G, Di Tommaso L, Del Duca S, Roncaroli F, Dal Monte PR (1998) Identification of mitochondria in liver biopsies. A study by immunohistochemistry, immunogold and Western blot analysis. Virchows Arch 433:267-273.
7. Kato K, Takayama T, Sano H, Katada N, Takeichi M (1984) Clinical investigation of fatty liver by CT. Acta Heptol Jpn (Kanzou) 25:1097-1103.
8. Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H (2005) Difference and similarity between nonalcoholic steatohepatitis and alcoholic liver disease. Alcohol Clin Exp Res 29:259S-263S.
9. Loguercio C, De Girolamo V, de Sio I, Tuccillo C, Ascione A, Baldi F, Budillon G, Cimino L, Di Carlo A, Di Marino MP, Morisco F, Picciotto F, Terracciano L, Vecchione R, Verde V, Del Vecchio Blanco C (2001) Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35:568-574.
10. Ludwig J, Viggiano TR, McGill DB, et al (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438.
11. Namikawa C, Shu-Ping Z, Vyselaar JR, Nozaki Y, Nemoto Y, Ono M, Akisawa N, Saibara T, Hiroi M, Enzan H, Onishi S (2004) Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40:781-786.
12. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120:1183-1192.
13. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K (2002) In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol 37:56-62.
14. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Kashima K, Nakamura H, Yodoi J (2003) Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38:32-38.
15. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27:128-133.
16. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94:2557-2562.